TMEM198
Transmembrane protein 198
Also known as: MGC99813, TM198_HUMAN, TMEM198A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q66K66
- Gene
- TMEM198
- Ensembl
- ENSG00000188760
- Chromosome
- 2
- Canonical length
- 360 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Involved in positive regulation of canonical Wnt signaling pathway. Located in cytoplasmic vesicle and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
360 residues, UniProt reviewed canonical sequence.
>Q66K66|TMEM198
1 MPGTVATLRF QLLPPEPDDA FWGAPCEQPL ERRYQALPAL VCIMCCLFGV VYCFFGYRCF
61 KAVLFLTGLL FGSVVIFLLC YRERVLETQL SAGASAGIAL GIGLLCGLVA MLVRSVGLFL
121 VGLLLGLLLA AAALLGSAPY YQPGSVWGPL GLLLGGGLLC ALLTLRWPRP LTTLATAVTG
181 AALIATAADY FAELLLLGRY VVERLRAAPV PPLCWRSWAL LALWPLLSLM GVLVQWRVTA
241 EGDSHTEVVI SRQRRRVQLM RIRQQEDRKE KRRKKRPPRA PLRGPRAPPR PGPPDPAYRR
301 RPVPIKRFNG DVLSPSYIQS FRDRQTGSSL SSFMASPTDA DYEYGSRGPL TACSGPPVRVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM198 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 17 nTPM
- cerebellum: 15 nTPM
- cerebral cortex: 15 nTPM
- hippocampal formation: 14 nTPM
- ovary: 14 nTPM
- basal ganglia: 11 nTPM
Single-cell type
- tuft cells: 46 nCPM
- adrenal medulla cells: 43 nCPM
- epicardial cells: 41 nCPM
- cardiomyocytes: 26 nCPM
- neuroendocrine cells: 16 nCPM
- decidual stromal cells: 16 nCPM
Immune cell
- plasmacytoid DC: 0.4 nTPM
- NK-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- hippocampal formation: 44 nTPM
- cerebral cortex: 40 nTPM
- cerebellum: 25 nTPM
- amygdala: 22 nTPM
- basal ganglia: 20 nTPM
- hypothalamus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.41
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TM7S3/TM198-like domain
- TM7S3/TM198-like domain
- Transmembrane protein 198
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM198 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM198 as an antibody target. Whether an autoantibody or antibody against TMEM198 could matter depends on whether native TMEM198 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM198 is annotated at the cell surface, where native TMEM198 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TMEM198 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...